| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,566 |
3,458 |
$356K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,102 |
4,955 |
$256K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,395 |
3,313 |
$146K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,310 |
1,309 |
$110K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,091 |
1,091 |
$101K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
932 |
932 |
$79K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,411 |
1,363 |
$72K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
667 |
664 |
$53K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
4,775 |
4,771 |
$44K |
| 90461 |
|
1,205 |
1,204 |
$41K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
460 |
452 |
$38K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,252 |
3,246 |
$34K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
534 |
521 |
$17K |
| 96127 |
|
1,391 |
1,391 |
$14K |
| 92552 |
|
333 |
333 |
$8K |
| 99173 |
|
289 |
289 |
$6K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
304 |
303 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
414 |
408 |
$5K |
| 99188 |
|
173 |
173 |
$4K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
223 |
220 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
182 |
179 |
$3K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
16 |
16 |
$3K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
26 |
26 |
$2K |
| 99050 |
|
137 |
137 |
$2K |
| 99051 |
|
129 |
129 |
$2K |
| 87081 |
|
305 |
303 |
$2K |
| 87634 |
|
32 |
32 |
$2K |
| 0081A |
|
38 |
38 |
$2K |
| 0124A |
|
30 |
30 |
$1K |
| 85018 |
|
449 |
448 |
$966.76 |
| 0004A |
|
13 |
13 |
$596.44 |